IMIST


Aging and Heart Failure (notice n° 37950)

000 -LEADER
fixed length control field 05570nam a22004815i 4500
001 - CONTROL NUMBER
control field 978-1-4939-0268-2
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20211202184434.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140219s2014 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781493902682
-- 978-1-4939-0268-2
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-4939-0268-2
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC681-688.2
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJD
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED010000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.12
Edition number 23
245 10 - TITLE STATEMENT
Title Aging and Heart Failure
Medium [electronic resource] :
Remainder of title Mechanisms and Management /
Statement of responsibility, etc edited by Bodh I. Jugdutt.
264 #1 -
-- New York, NY :
-- Springer New York :
-- Imprint: Springer,
-- 2014.
300 ## - PHYSICAL DESCRIPTION
Extent XXII, 475 p. 84 illus., 50 illus. in color.
Other physical details online resource.
336 ## - CONTENT TYPE
Content Type Term text
Content Type Code txt
Source rdacontent
337 ## - MEDIA TYPE
Media Type Term computer
Media Type Code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier Type Term online resource
Carrier Type Code cr
Source rdacarrier
347 ## -
-- text file
-- PDF
-- rda
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Changing demographics of the aging population with heart failure and implications for therapy -- Biology of aging and implications for heart failure therapy and prevention -- Hypertension and prevention of diastolic heart failure in the aging population -- Aging and optimal therapy of systolic heart failure in the elderly -- Atrial fibrillation and heart failure in the aging population -- Optimizing therapy of heart failure in the aging population with monitoring in clinics -- Cardiac alterations in aging, hypertension and diastolic heart failure -- Polypharmacy and adverse drug reactions in the aging population with heart failure -- Aging-related changes in vascular biology and implications for heart failure therapy in the aging population -- Biomarkers and optimal management of heart failure in the aging population -- Benefits of Exercise in the elderly -- The RAAS in heart failure: an update on clinical trials and opportunities for therapy -- Aging and diastolic dysfunction – the interplay of inflammation and extracellular matrix regulation -- Reperfusion and vasodilator therapy in elderly patients with STEMI and heart failure. Improving outcomes -- Erythropoietin therapy for heart failure -- Role of resistin in heart failure in the elderly -- Role of coronary artery calcium in cardiovascular risk stratification and management in the aging population -- Aging-and remodeling of the RAS and RAAS and related pathways. Implications for heart failure therapy -- Aging and right ventricular failure from pulmonary hypertension: Effect of right ventricular and pulmonary artery remodeling -- Biomarkers of cardiovascular aging -- Changes in the heart that accompany advancing age: Humans to molecules -- Aging-related changes in cell death and cell survival pathways and implications for heart failure therapy -- Aging-related changes in telomeres and telomerases and implications for heart failure therapy -- Aging associated alterations in myocardial inflammation and fibrosis: pathophysiological perspectives and clinical implications -- Aging-related changes in extracellular matrix: implications for ventricular remodeling following myocardial infarction -- Calcium handling defects and changes in cardiac function in the aging heart -- Integrins: Implications for aging in heart failure therapy -- Adipokines as novel biomarkers in aging and heart failure -- Aging-related changes in cellular and molecular mechanisms of post-infarction remodeling. Implications for heart failure therapy -- Aging-related changes in mitochondrial function and implication for heart failure therapy -- Regulation of SERCA via oxidative modifications: Implications for the pathophysiology of diastolic dysfunction in the aging heart -- SMP-30 and aging-related cardiac remodeling and heart failure.
520 ## - SUMMARY, ETC.
Summary, etc This book synthesizes the major research advances in molecular, biochemical, and translational aspects of aging and heart failure over the last four decades and addresses future directions in management and drug discovery. It presents clinical issues and molecular mechanisms related to heart failure, including the changing demographics in the aging population with heart failure; hypertension and prevention of diastolic heart failure in the aging population; polypharmacy and adverse drug reactions in the aging population with heart failure; changes in the heart that accompany advancing age from humans to molecules; aging-associated alterations in myocardial inflammation and fibrosis; and aging-related changes in mitochondrial function and implications for heart failure therapy. The book succinctly summarizes the large volume of data on these key topics and highlights novel pathways that need to be explored. Featuring contributions from leading clinician-scientists, Aging and Heart Failure: Mechanisms and Management is an authoritative resource on the major clinical issues in heart failure therapy in the elderly for cardiologists, gerontologists, and internists.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
9 (RLIN) 101542
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Internal medicine.
9 (RLIN) 101543
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cardiology.
9 (RLIN) 101544
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Geriatrics.
9 (RLIN) 101545
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine & Public Health.
9 (RLIN) 101546
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cardiology.
9 (RLIN) 101544
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Geriatrics/Gerontology.
9 (RLIN) 101547
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Internal Medicine.
9 (RLIN) 101548
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jugdutt, Bodh I.
Relator term editor.
9 (RLIN) 91130
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
9 (RLIN) 25138
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9781493902675
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://dx.doi.org/10.1007/978-1-4939-0268-2">http://dx.doi.org/10.1007/978-1-4939-0268-2</a>
912 ## -
-- ZDB-2-SME
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Ebook
956 ## - LOCAL ELECTRONIC LOCATION AND ACCESS (OCLC)
Electronic name Springer

Pas d'exemplaire disponible.

© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha